First Light Asset Management, LLC Crinetics Pharmaceuticals, Inc. Transaction History
First Light Asset Management, LLC
- $651 Million
- Q2 2025
A detailed history of First Light Asset Management, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, First Light Asset Management, LLC holds 864,136 shares of CRNX stock, worth $38.3 Million. This represents 3.82% of its overall portfolio holdings.
Number of Shares
864,136
Previous 855,419
1.02%
Holding current value
$38.3 Million
Previous $28.7 Million
13.38%
% of portfolio
3.82%
Previous 3.68%
Shares
14 transactions
Others Institutions Holding CRNX
# of Institutions
238Shares Held
90.2MCall Options Held
59.7KPut Options Held
14.8K-
Vanguard Group Inc Valley Forge, PA9.26MShares$410 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.4MShares$284 Million1.78% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$276 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.81MShares$257 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.59MShares$248 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.38B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...